Intra-Cellular Therapies Inc. Stock Forecast

Red day on Wednesday for Intra-Cellular Therapies Inc. stock after losing 1.20%
(Updated on Apr 24, 2024)

ITCI Signals & Forecast

The Intra-Cellular Therapies Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $74.65. On a fall, the stock will find some support from the long-term average at approximately $68.48. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -8.42%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Friday, April 05, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Intra-Cellular Therapies Inc. stock

Intra-Cellular Therapies Inc. finds support from accumulated volume at $72.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.70 between high and low, or 2.34%. For the last week, the stock has had daily average volatility of 4.30%.

Our recommended stop-loss: $68.85 (-5.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (ITCI) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Intra-Cellular Therapies Inc. to open at $73.21, and during the day (based on 14 day Average True Range), to move between $69.52 and $76.72, which gives a possible trading interval of +/-$3.60 (+/-4.93%) up or down from last closing price. If Intra-Cellular Therapies Inc. takes out the full calculated possible swing range there will be an estimated 9.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $72.37 (1.03%) than the resistance at $74.54 (1.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Intra-Cellular Therapies Inc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Intra-Cellular Therapies Inc. stock to perform well in the short-term period.

Current score: 1.260 Buy Candidate Unchanged

Predicted Opening Price for Intra-Cellular Therapies Inc. of Thursday, April 25, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.